Skip to main content
OpenTrials

Clinical trial condition

Myositis

Explore clinical trials studying Myositis. Study availability and eligibility vary by location and protocol.

160 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myositis trial results

Recruiting

Adult and Juvenile Myositis

NCT00017914

Conditions
Connective Tissue Diseases, Dermatomyositis, Inclusion Body Myositis, +9 more
Locations
  • Emory University Atlanta, Georgia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States
  • Texas Scottish Rite Hospital Dallas, Texas, United States
View Trial Details
Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

NCT06154252

Conditions
Anti-synthetase Syndrome, Autoimmune Diseases, Connective Tissue Diseases, +16 more
Locations
  • University of California Irvine - Accepting Adult Patients Orange, California, United States
  • University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients San Francisco, California, United States
  • Children's Hospital Colorado - Accepting Juvenile Patients Aurora, Colorado, United States
  • Mayo Clinic Florida - Accepting Adult Patients Jacksonville, Florida, United States
View all 35 locations
View Trial Details
Recruiting

FT839 in Autoimmune Diseases

NCT07800871

Conditions
ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +26 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Recruiting

Descartes-08 in Autoantibody Myositis

NCT07391605

Conditions
Antisynthetase Syndrome, Antisynthetase syndrome, Muscular Diseases, +4 more
Locations
  • University of California, Irvine Orange, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • National Neuromuscular Research Institute Austin, Texas, United States
View Trial Details
Recruiting

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

NCT07103746

Conditions
Autoimmune Diseases, Autoimmune Disorders, Immune System Diseases, +5 more
Locations
  • University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology Birmingham, Alabama, United States
  • Emory University School of Medicine: Division of Rheumatology Atlanta, Georgia, United States
  • University of Chicago, Department of Medicine: Rheumatology Chicago, Illinois, United States
  • Johns Hopkins Hospital: Division of Rheumatology Baltimore, Maryland, United States
View Trial Details
Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details

Related conditions